Novo Nordisk says drug helped diabetics lose 6% of weight
This article was originally published in Scrip
Executive Summary
Novo Nordisk said a high dose of its diabetes drug Victoza (liraglutide) helped patients in a study lose 6% of their body weight, a finding that will be used in the company’s application for a new obesity treatment.